Keyphrases
Phosphorylation
100%
AMP-activated Protein Kinase
100%
Protein Kinase Inhibitors
100%
SBI-0206965
100%
Signaling Pathway
16%
High Concentration
16%
Pharmaceutical Industry
16%
Dephosphorylation
16%
Liver Kinase B1 (LKB1)
16%
Downstream Targets
16%
Type 2 Diabetes Mellitus (T2DM)
16%
Catalytic Subunit
16%
Subunit Isoform
16%
Anabolic Effect
16%
Subcellular Compartments
16%
Non-alcoholic Fatty Liver Disease (NAFLD)
16%
Metabolic Disorders
16%
Lung Adenocarcinoma
16%
Off-target Effects
16%
AMP-activated Protein Kinase Phosphorylation
16%
Energy Stress
16%
Catabolic Activity
16%
Cell Studies
16%
PRKAA1
16%
Metabolic Switch
16%
Low Bioavailability
16%
Medicine and Dentistry
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
100%
Protein Kinase Inhibitor
100%
Signal Transduction
14%
Cancer
14%
Adenosine Phosphate
14%
Maturity Onset Diabetes of the Young
14%
Adenosine Triphosphate
14%
Bioavailability
14%
Enzyme Active Site
14%
Lung Adenocarcinoma
14%
Nonalcoholic Fatty Liver
14%
Dephosphorylation
14%
Metabolic Disorder
14%
Pharmacology, Toxicology and Pharmaceutical Science
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
100%
Protein Kinase Inhibitor
100%
Adenosine Triphosphate
14%
Adenosine Phosphate
14%
Bioavailability
14%
Lung Adenocarcinoma
14%
Nonalcoholic Fatty Liver
14%
Non Insulin Dependent Diabetes Mellitus
14%
Neuroscience
AMP-activated Protein Kinase
100%
Protein Kinase Inhibitor
100%
In Vivo
14%
Adenosine Triphosphate
14%
Enzyme Active Site
14%
Dephosphorylation
14%
Adenosine Monophosphate
14%